Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Cell Reports|September 24, 2013
Characterization and analysis of the composition and dynamics of the mammalian riboproteomeMarkus Reschke, John G Clohessy, Nina Seitzer, et al.Experimental Hematology|November 5, 2013
NPMc+ cooperates with Flt3/ITD mutations to cause acute leukemia recapitulating human diseaseRachel Rau, Daniel Magoon, Sarah Greenblatt, et al.Nature Medicine|January 9, 2018
Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanismsMarco Bezzi, Nina Seitzer, Tomoki Ishikawa, et al.Cell Stem Cell|January 21, 2014
Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenanceLev M Kats, Markus Reschke, Riccardo Taulli, et al.Scientific Reports|November 19, 2020
Identification of the HECT E3 ligase UBR5 as a regulator of MYC degradation using a CRISPR/Cas9 screenLina Schukur, Tamara Zimmermann, Ole Niewoehner, et al.Oncoimmunology|June 27, 2022
Combination of two novel blocking antibodies, anti-PD-1 antibody ezabenlimab (BI 754091) and anti-LAG-3 antibody BI 754111, leads to increased immune cell responsesMarkus Zettl, Melanie Wurm, Otmar Schaaf, et al.The Journal of Pharmacology and Experimental Therapeutics|January 11, 2015
Efficacy and mechanism of action of volasertib, a potent and selective inhibitor of Polo-like kinases, in preclinical models of acute myeloid leukemiaDorothea Rudolph, Maria Antonietta Impagnatiello, Claudia Blaukopf, et al.Cell|April 7, 2015
The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivoFlorian A Karreth, Markus Reschke, Anna Ruocco, et al.Nature Medicine|April 8, 2015
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancerShuo Wei, Shingo Kozono, Lev Kats, et al.Human Molecular Genetics|September 1, 2018
Loss of LDAH associated with prostate cancer and hearing lossBenjamin B Currall, Ming Chen, Richard C Sallari, et al.Pageof 3